Abstract:Objective To compare the anesthetic effect, safety and side effects of oxycodone plus midazolam versus sufentanil plus midazolam in painless colonoscopy.Methods 60 patients underwent painless colonoscopy were randomly divided into two groups according to the random number table. Age: 18~65 years old; Body mass index: 18.5~27.0 kg/m2; ASA Ⅰ~Ⅲ level. Five minutes before colonoscopy, all the patients received slowly intravenous injection of midazolam 0.05 mg/kg. Then, group O (oxycodone group) was given 0.10 mg/kg oxycodone, and group S (sufentanil group) was given 0.10 μg/kg sufentanil. During the operation, propofol intravenous injection of 10~30 mg could be administered according to the patient's examination and cooperation. Heart rate, noninvasive blood pressure and oxygen saturation were continuously monitored. Induction time, operation time, resuscitation time and Time-out of operating room were recorded. Adverse reactions such as hypotension, hypoxia saturation, nausea and vomiting were recorded. Anesthesiologist satisfaction immediately, gastroenterologist (operator) satisfaction immediately, and patient satisfaction one week after the operation were recorded.Results Induction time, operation time, resuscitation time, Time-out of operating room, the incidence of hypotension, severe hypoxemia there was no significant difference between the two groups (P > 0.05), the group S of propofol additional rate significantly greater than the O group (P < 0.05). The incidence of mild hypoxemia in S group was obviously higher than that of O group (P < 0.05). Digestive physician satisfaction in S group is signficantly lower than that of the O group (P < 0.05); Satisfaction of anesthesiologists in group S was obviously lower than that in group O (P < 0.05). There was no significant difference in patient satisfaction between the two groups (P > 0.05).Conclusion Oxycodone combined with midazolam is safe and effective in outpatient colonoscopy, has a lower incidence of mild hypoxemia and the addition of propofol than sufentanil combined with midazolam.